Immutep Limited

Immutep Limitedverified

PRRUF

Price:

$0.05

Market Cap:

$69.26M

Immutep Limited, an Australian biotechnology firm established in 1987, is focused on the discovery and development of innovative immunotherapeutic pharmaceuticals. The company's pipeline primarily targets cancer and autoimmune diseases. Its flagship product, eftilagimod alpha (also known as efti or IMP321), is currently in a Phase IIb clinical trial, investigating its efficacy as a chemo-immunotherapy combination for metastatic breast cancer. Additional oncology candidates include TACTI-002, undergoing Phase II trials for head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer, and TACTI-003, in Phase IIb trials for HNSCC. The company is also evaluating INSIGHT-003 in a ...[Read more]

Industry

Biotechnology

IPO Date

2012-02-22

Stock Exchange

OTC

Ticker

PRRUF

The ROE as of June 2026 (TTM) for Immutep Limited (PRRUF) is -69.20%

According to Immutep Limited’s latest financial reports and current stock price. The company's current ROE is -69.20%. This represents a change of 185.76% compared to the average of -24.22% of the last 4 quarters.

Immutep Limited (PRRUF) Historical ROE (quarterly & annually)

How has PRRUF ROE performed in the past?

The mean historical ROE of Immutep Limited over the last ten years is -52.57%. The current -69.20% ROE has changed 31.64% with respect to the historical average. Over the past ten years (40 quarters), PRRUF's ROE was at its highest in in the December 2007 quarter at 0%. The ROE was at its lowest in in the December 2015 quarter at -138.26%.

Quarterly (TTM)
Annual

Average

-52.57%

Median

-39.23%

Minimum

-175.59%

Maximum

-22.54%

Immutep Limited (PRRUF) ROE by Quarter and Year

Discovering the peaks and valleys of Immutep Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 89.76%

Maximum Annual ROE = -22.54%

Minimum Annual Increase = -79.89%

Minimum Annual ROE = -175.59%

Quarterly (TTM)
Annual
YearROEChange
2025-42.77%89.76%
2024-22.54%-22.90%
2023-29.23%-14.62%
2022-34.24%-16.10%
2021-40.81%0.90%
2020-40.45%-39.38%
2019-66.72%75.46%
2018-38.02%7.70%
2017-35.30%-79.89%
2016-175.59%34.84%

Immutep Limited (PRRUF) Average ROE

How has PRRUF ROE performed in the past?

The current ROE of Immutep Limited (PRRUF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-31.51%

5-year avg

-33.92%

10-year avg

-52.57%

Immutep Limited (PRRUF) ROE vs. Peers

How is PRRUF’s ROE compared to its peers?

Immutep Limited’s ROE is greater than Cellectis S.A. (-80.61%), less than CytoDyn Inc. (36.98%), greater than Transgene S.A. (-63.53%), less than Northwest Biotherapeutics, Inc. (62.41%), less than Clinuvel Pharmaceuticals Limited (13.29%), less than Hansa Biopharma AB (publ) (201.60%), less than Frontage Holdings Corporation (1.98%), less than Clinuvel Pharmaceuticals Limited (13.29%), greater than Healios K.K. (-75.40%), greater than Silence Therapeutics plc (-121.71%),

Build a custom stock screener for Immutep Limited (PRRUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (PRRUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Immutep Limited's ROE?

How is the ROE calculated for Immutep Limited (PRRUF)?

What is the highest ROE for Immutep Limited (PRRUF)?

What is the 3-year average ROE for Immutep Limited (PRRUF)?

What is the 5-year average ROE for Immutep Limited (PRRUF)?

How does the current ROE for Immutep Limited (PRRUF) compare to its historical average?